Johnson Pharmacare Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | -0.33 | TBA | TBA |
| Operating Expense | 0.18 | 0.03 | TBA |
| Net Profit | -0.51 | -0.03 | TBA |
| Net Profit Margin | 154.55 | TBA | TBA |
| Earning Per Share | -0.01 | TBA | TBA |
| EBIDTA | -0.51 | -0.03 | TBA |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Mar 2025 |
|---|---|
| Revenue | -0.33 |
| Operating Expense | 0.18 |
| Net Profit | -0.51 |
| Net Profit Margin | 154.55 |
| Earning Per Share | -0.01 |
| EBIDTA | -0.51 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | TBA | 2.53 | 3.26 |
| Operating Expenses Annual | 0.20 | 3.86 | 3.13 |
| Operating Profit Annual | -0.20 | -1.33 | 0.13 |
| Interest Annual | TBA | TBA | TBA |
| Depreciation | TBA | TBA | TBA |
| Net Profit Annual | -0.20 | -1.29 | 0.10 |
| Tax Annual | TBA | -0.04 | 0.04 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | TBA |
| Operating Expenses Annual | 0.20 |
| Operating Profit Annual | -0.20 |
| Interest Annual | TBA |
| Depreciation | TBA |
| Net Profit Annual | -0.20 |
| Tax Annual | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | TBA | 0.04 | 0.23 |
| Cash Flow from Operations | -0.05 | -0.40 | 4.90 |
| Cash Flow from Investing | TBA | -0.94 | -5.01 |
| Cash Flow from Financing | 0.05 | 1.30 | -0.08 |
| Cash Flow at the End | TBA | TBA | 0.04 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | TBA |
| Cash Flow from Operations | -0.05 |
| Cash Flow from Investing | TBA |
| Cash Flow from Financing | 0.05 |
| Cash Flow at the End | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | TBA | 8.70 | 3.99 |
| PBIT Margin (%) | TBA | 8.70 | 3.99 |
| PBT Margin (%) | TBA | 8.70 | 3.99 |
| Net PROFIT Margin (%) | TBA | -50.99 | 3.07 |
| Return On Networth / Equity (%) | TBA | TBA | 0.17 |
| Return On Networth /Employed (%) | TBA | TBA | 0.24 |
| Return On Assets (%) | TBA | -2.04 | 0.18 |
| Total Debt / Equity (X) | 0.03 | 0.02 | 0.01 |
| Asset Turnover Ratio (%) | TBA | 0.04 | 0.06 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | TBA |
| PBIT Margin (%) | TBA |
| PBT Margin (%) | TBA |
| Net PROFIT Margin (%) | TBA |
| Return On Networth / Equity (%) | TBA |
| Return On Networth /Employed (%) | TBA |
| Return On Assets (%) | TBA |
| Total Debt / Equity (X) | 0.03 |
| Asset Turnover Ratio (%) | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | TBA | TBA | TBA |
| Total Current Assets Annual | 0.00 | 0.00 | 1.09 |
| Non Current Assets Annual | 59.83 | 59.83 | 58.89 |
| Total Shareholders Funds Annual | 56.75 | 56.95 | 58.24 |
| Total Assets Annual | 59.83 | 59.83 | 59.98 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | TBA |
| Total Current Assets Annual | 0.00 |
| Non Current Assets Annual | 59.83 |
| Total Shareholders Funds Annual | 56.75 |
| Total Assets Annual | 59.83 |
No Data Availabe
